Surgery Grand Rounds and Case Conference

October 9, 2013

Duke North – Room 2002

Surgical Grand Rounds

7:00 – 8:00 a.m.

“Pancreas Cancer: Progress, Disappointments and Opportunities”

Charles J. Yeo, M.D.

The Samuel D. Gross Professor and Chairman

Department of Surgery

Jefferson Medical College/Thomas Jefferson University

Moderator:

Mary E. Klotman, M.D.

Chair, Department of Medicine

Chair, Surgery Chair Search Committee

8:00 – 8:30 a.m.

“The Prognostic Importance of the Number of Dissected Lymph Nodes after Induction Chemoradiation for Esophageal Cancer”

Jennifer Hanna, M.D.

Senior Assistant Resident I

General Surgery

Moderator:  Thomas A. D’Amico, M.D.

Surgical Case Conference

8:30 – 9:00 a.m.

Moderator:  Steven N. Vaslef, M.D., Ph.D.

Presenter Disclosure of Financial Relationships: Drs. Yeo, Vaslef, and Hanna indicate they have no financial relationships relative to the content presented and no personal/financial relationships to disclose which are relative to this activity.  Dr. Klotman indicates she is an Advisory Board Member for Gilead and a Consultant for UpToDate, but has no personal/financial relationships to disclose which are relative to this activity.  Dr. D’Amico indicates he is a consultant for Scanlan, but has no personal/financial relationships to disclose which are relative to this activity.

RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.

---Global Learning Objectives---

1. Review and discuss new advances in general surgery;
2. Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
3. Review and discuss clinical research findings and other evidence from pertinent literature.

---Accreditation Information---

The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

---Unapproved Use Disclosure---

Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion.  Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications.  If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

---Credit Designation---

The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in this activity. 

In order to receive Credit, learners must sign in at the beginning of this event.